| Year |
Citation |
Score |
| 2024 |
Woodcock DJ, Sahli A, Teslo R, Bhandari V, Gruber AJ, Ziubroniewicz A, Gundem G, Xu Y, Butler A, Anokian E, Pope BJ, Jung CH, Tarabichi M, Dentro SC, Farmery JHR, ... ... Fraser M, et al. Genomic evolution shapes prostate cancer disease type. Cell Genomics. 100511. PMID 38428419 DOI: 10.1016/j.xgen.2024.100511 |
0.664 |
|
| 2022 |
Chen S, Petricca J, Ye W, Guan J, Zeng Y, Cheng N, Gong L, Shen SY, Hua JT, Crumbaker M, Fraser M, Liu S, Bratman SV, van der Kwast T, Pugh T, et al. The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors. Nature Communications. 13: 6467. PMID 36309516 DOI: 10.1038/s41467-022-34012-2 |
0.444 |
|
| 2022 |
Sjöström M, Zhao SG, Levy S, Zhang M, Ning Y, Shrestha R, Lundberg A, Herberts C, Foye A, Aggarwal R, Hua JT, Li H, Bergamaschi A, Maurice-Dror C, Maheshwari A, ... ... Fraser M, et al. The 5-Hydroxymethylcytosine Landscape of Prostate Cancer. Cancer Research. OF1-OF15. PMID 36251389 DOI: 10.1158/0008-5472.CAN-22-1123 |
0.531 |
|
| 2022 |
Burns D, Anokian E, Saunders EJ, Bristow RG, Fraser M, Reimand J, Schlomm T, Sauter G, Brors B, Korbel J, Weischenfeldt J, Waszak SM, Corcoran NM, Jung CH, Pope BJ, et al. Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study. European Urology. PMID 35659150 DOI: 10.1016/j.eururo.2022.05.007 |
0.664 |
|
| 2021 |
Livingstone J, Shiah YJ, Yamaguchi TN, Heisler LE, Huang V, Lesurf R, Gebo T, Carlin B, Eng S, Drysdale E, Green J, van der Kwast T, Bristow RG, Fraser M, Boutros PC. The telomere length landscape of prostate cancer. Nature Communications. 12: 6893. PMID 34824250 DOI: 10.1038/s41467-021-27223-6 |
0.621 |
|
| 2021 |
Plante A, Dallaire F, Grosset AA, Nguyen T, Birlea M, Wong J, Daoust F, Roy N, Kougioumoutzakis A, Azzi F, Aubertin K, Kadoury S, Latour M, Albadine R, Prendeville S, ... ... Fraser M, et al. Dimensional reduction based on peak fitting of Raman micro spectroscopy data improves detection of prostate cancer in tissue specimens. Journal of Biomedical Optics. 26. PMID 34743445 DOI: 10.1117/1.JBO.26.11.116501 |
0.477 |
|
| 2021 |
Fraser M, Livingstone J, Wrana JL, Finelli A, He HH, van der Kwast T, Zlotta AR, Bristow RG, Boutros PC. Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse. Nature Communications. 12: 6248. PMID 34716314 DOI: 10.1038/s41467-021-26489-0 |
0.65 |
|
| 2021 |
Hawley JR, Zhou S, Arlidge C, Grillo G, Kron KJ, Hugh-White R, van der Kwast TH, Fraser M, Boutros PC, Bristow RG, Lupien M. Reorganization of the 3D genome pinpoints non-coding drivers of primary prostate tumors. Cancer Research. PMID 34642184 DOI: 10.1158/0008-5472.CAN-21-2056 |
0.6 |
|
| 2021 |
Ahmed M, Soares F, Xia JH, Yang Y, Li J, Guo H, Su P, Tian Y, Lee HJ, Wang M, Akhtar N, Houlahan KE, Bosch A, Zhou S, Mazrooei P, ... ... Fraser M, et al. CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer. Nature Communications. 12: 1781. PMID 33741908 DOI: 10.1038/s41467-021-21867-0 |
0.379 |
|
| 2021 |
Chen S, Zhu G, Yang Y, Wang F, Xiao YT, Zhang N, Bian X, Zhu Y, Yu Y, Liu F, Dong K, Mariscal J, Liu Y, Soares F, Loo Yau H, ... ... Fraser M, et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nature Cell Biology. 23: 87-98. PMID 33420488 DOI: 10.1038/s41556-020-00613-6 |
0.462 |
|
| 2021 |
Fraser M. Evidence for Focal Grade Group Progression in Low-risk Prostate Cancer. European Urology. 79: 466-467. PMID 33357993 DOI: 10.1016/j.eururo.2020.11.022 |
0.463 |
|
| 2021 |
Fraser M. Evidence for Focal Grade Group Progression in Low-risk Prostate Cancer European Urology. 79: 466-467. DOI: 10.1016/j.eururo.2020.11.022 |
0.463 |
|
| 2020 |
Grosset AA, Dallaire F, Nguyen T, Birlea M, Wong J, Daoust F, Roy N, Kougioumoutzakis A, Azzi F, Aubertin K, Kadoury S, Latour M, Albadine R, Prendeville S, Boutros P, ... Fraser M, et al. Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation. Plos Medicine. 17: e1003281. PMID 32797086 DOI: 10.1371/Journal.Pmed.1003281 |
0.616 |
|
| 2020 |
Brastianos HC, Murgic J, Salcedo A, Chua MLK, Meng A, Fraser M, Brundage M, Fleshner NE, van der Kwast T, Bristow RG, Boutros PC, Berlin A. Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer. European Urology Oncology. PMID 32605887 DOI: 10.1016/J.Euo.2020.06.005 |
0.64 |
|
| 2020 |
Zhou S, Hawley JR, Soares F, Grillo G, Teng M, Madani Tonekaboni SA, Hua JT, Kron KJ, Mazrooei P, Ahmed M, Arlidge C, Yun HY, Livingstone J, Huang V, Yamaguchi TN, ... ... Fraser M, et al. Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer. Nature Communications. 11: 441. PMID 31974375 DOI: 10.1038/S41467-020-14318-9 |
0.657 |
|
| 2020 |
Li Y, Yang R, Henzler CM, Ho Y, Passow C, Auch B, Carreira S, Nava Rodrigues D, Bertan C, Hwang TH, Quigley DA, Dang HX, Morrissey C, Fraser M, Plymate SR, et al. Diverse AR Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31932493 DOI: 10.1158/1078-0432.Ccr-19-3023 |
0.574 |
|
| 2019 |
Fraser M, Rouette A. Prostate Cancer Genomic Subtypes. Advances in Experimental Medicine and Biology. 1210: 87-110. PMID 31900906 DOI: 10.1007/978-3-030-32656-2_5 |
0.581 |
|
| 2019 |
Mazrooei P, Kron KJ, Zhu Y, Zhou S, Grillo G, Mehdi T, Ahmed M, Severson TM, Guilhamon P, Armstrong NS, Huang V, Yamaguchi TN, Fraser M, van der Kwast T, Boutros PC, et al. Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors. Cancer Cell. PMID 31735626 DOI: 10.1016/J.Ccell.2019.10.005 |
0.611 |
|
| 2019 |
Houlahan KE, Shiah YJ, Gusev A, Yuan J, Ahmed M, Shetty A, Ramanand SG, Yao CQ, Bell C, O'Connor E, Huang V, Fraser M, Heisler LE, Livingstone J, Yamaguchi TN, et al. Genome-wide germline correlates of the epigenetic landscape of prostate cancer. Nature Medicine. PMID 31591588 DOI: 10.1038/S41591-019-0579-Z |
0.602 |
|
| 2019 |
Jeon J, Olkhov-Mitsel E, Xie H, Yao CQ, Zhao F, Jahangiri S, Cuizon C, Scarcello S, Jeyapala R, Watson JD, Fraser M, Ray J, Commisso K, Loblaw A, Fleshner NE, et al. Temporal stability and prognostic biomarker potential of the prostate cancer urine transcriptome. Journal of the National Cancer Institute. PMID 31161221 DOI: 10.1093/Jnci/Djz112 |
0.611 |
|
| 2019 |
Fraser M. Separating the Dreadful from the Merely Bad: Towards Prognostic and Predictive Biomarkers in Metastatic Castration-resistant Prostate Cancer. European Urology. 76: 572-573. PMID 31010599 DOI: 10.1016/J.Eururo.2019.04.005 |
0.534 |
|
| 2019 |
Sinha A, Huang V, Livingstone J, Wang J, Fox NS, Kurganovs N, Ignatchenko V, Fritsch K, Donmez N, Heisler LE, Shiah YJ, Yao CQ, Alfaro JA, Volik S, Lapuk A, ... Fraser M, et al. The Proteogenomic Landscape of Curable Prostate Cancer. Cancer Cell. 35: 414-427.e6. PMID 30889379 DOI: 10.1016/J.Ccell.2019.02.005 |
0.715 |
|
| 2019 |
Taylor RA, Fraser M, Rebello RJ, Boutros PC, Murphy DG, Bristow RG, Risbridger GP. The influence of BRCA2 mutation on localized prostate cancer. Nature Reviews. Urology. PMID 30808988 DOI: 10.1038/S41585-019-0164-8 |
0.653 |
|
| 2019 |
Chen S, Huang V, Xu X, Livingstone J, Soares F, Jeon J, Zeng Y, Hua JT, Petricca J, Guo H, Wang M, Yousif F, Zhang Y, Donmez N, Ahmed M, ... ... Fraser M, et al. Widespread and Functional RNA Circularization in Localized Prostate Cancer. Cell. 176: 831-843.e22. PMID 30735634 DOI: 10.1016/J.Cell.2019.01.025 |
0.586 |
|
| 2019 |
Bhandari V, Hoey C, Liu LY, Lalonde E, Ray J, Livingstone J, Lesurf R, Shiah YJ, Vujcic T, Huang X, Espiritu SMG, Heisler LE, Yousif F, Huang V, Yamaguchi TN, ... ... Fraser M, et al. Molecular landmarks of tumor hypoxia across cancer types. Nature Genetics. PMID 30643250 DOI: 10.1038/S41588-018-0318-2 |
0.549 |
|
| 2019 |
Fraser M, Koontz B, Emmenegger U, De Meerleer G, Khoo V, Feng F, Corcoran NM, Hovens CM, Tran PT, Ost P, Boutros PC. What Is Oligometastatic Prostate Cancer? European Urology Focus. PMID 30642810 DOI: 10.1016/J.Euf.2018.12.009 |
0.553 |
|
| 2019 |
Vinayak B, Liu L, Espirritu S, Lalonde E, Yamaguchi T, Heisler L, Livingstone J, Huang V, Shiah Y, Sabelnykova V, Yousif F, Fraser M, Chua M, Van Der Kwast T, Liu SK, et al. The molecular hallmarks and clinical consequences of tumor hypoxia in prostate cancer. Journal of Clinical Oncology. 37: 81-81. DOI: 10.1200/Jco.2019.37.7_Suppl.81 |
0.712 |
|
| 2019 |
Brastianos H, Murgic J, Salcedo A, Chua MLK, Meng A, Fraser M, Brundage MD, Fleshner NE, van der Kwast T, Bristow RG, Boutros PC, Berlin A. The impact of intratumoral heterogeneity on prognostic biomarkers in localized prostate cancer. Journal of Clinical Oncology. 37: 46-46. DOI: 10.1200/Jco.2019.37.7_Suppl.46 |
0.634 |
|
| 2019 |
Trudel D, Grosset A, Dallaire F, Nguyen T, Kougioumoutzakis A, Azzi F, Aubertin K, Saad F, Latour M, Albadine R, Boutros P, Fraser M, Bristow RG, Kwast Tvd, Benzerdjeb N, et al. Raman microscopy for the identification of an aggressive variant of prostate cancer, intraductal carcinoma of the prostate Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz239.002 |
0.578 |
|
| 2019 |
Brastianos H, Murgic J, Salcedo A, Chua M, Meng A, Fraser M, Brundage M, Fleshner N, van der Kwast T, Bristow R. 39 Determination of the Impact of Intratumoural Heterogeneity on Prognostic Biomarkers in Localized Prostate Cancer Radiotherapy and Oncology. 139: S19-S20. DOI: 10.1016/S0167-8140(19)33325-0 |
0.563 |
|
| 2018 |
Cooper CI, Yao D, Sendorek DH, Yamaguchi TN, P'ng C, Houlahan KE, Caloian C, Fraser M, Ellrott K, Margolin AA, Bristow RG, Stuart JM, Boutros PC. Valection: design optimization for validation and verification studies. Bmc Bioinformatics. 19: 339. PMID 30253747 DOI: 10.1186/S12859-018-2391-Z |
0.429 |
|
| 2018 |
Berlin A, Murgic J, Hosni A, Pintilie M, Salcedo A, Fraser M, Kamel-Reid S, Zhang J, Wang Q, Ch'ng C, Deheshi S, Davicioni E, van der Kwast T, Boutros PC, Bristow RG, et al. Genomic classifier for guiding treatment of intermediate-risk prostate cancers to dose-escalated image-guided radiotherapy without hormone therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 30170099 DOI: 10.1016/J.Ijrobp.2018.08.030 |
0.679 |
|
| 2018 |
Espiritu SMG, Liu LY, Rubanova Y, Bhandari V, Holgersen EM, Szyca LM, Fox NS, Chua MLK, Yamaguchi TN, Heisler LE, Livingstone J, Wintersinger J, Yousif F, Lalonde E, Rouette A, ... ... Fraser M, et al. The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression. Cell. PMID 29681457 DOI: 10.1016/J.Cell.2018.03.029 |
0.636 |
|
| 2018 |
Wedge DC, Gundem G, Mitchell T, Woodcock DJ, Martincorena I, Ghori M, Zamora J, Butler A, Whitaker H, Kote-Jarai Z, Alexandrov LB, Van Loo P, Massie CE, Dentro S, Warren AY, ... ... Fraser M, et al. Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets. Nature Genetics. PMID 29662167 DOI: 10.1038/S41588-018-0086-Z |
0.654 |
|
| 2018 |
Böttcher R, Kweldam CF, Livingstone J, Lalonde E, Yamaguchi TN, Huang V, Yousif F, Fraser M, Bristow RG, van der Kwast T, Boutros PC, Jenster G, van Leenders GJLH. Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations. Bmc Cancer. 18: 8. PMID 29295717 DOI: 10.1186/S12885-017-3976-Z |
0.652 |
|
| 2018 |
Chua M, Murgic J, Hosni A, Salcedo A, Kamel-Reid S, Berlin A, Pintile M, Fraser M, Van Der Kwast T, Boutros PC, Bristow RG. A biopsy-based genomic classifier to predict biochemical failure after definitive radiation without hormone therapy in a prospective cohort of intermediate risk prostate cancer. Journal of Clinical Oncology. 36: 68-68. DOI: 10.1200/Jco.2018.36.6_Suppl.68 |
0.657 |
|
| 2018 |
Porter LH, Lawrence MG, Pezaro C, Thorne H, Ilic D, Papargiris M, Fraser M, Livingstone J, Murphy DG, Frydenberg M, Bolton D, Moon D, Clouston D, Kwast Tvd, Boutros PC, et al. Abstract B100: High-risk pathologic and genomic features of BRCA2-mutant prostate cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-B100 |
0.677 |
|
| 2018 |
Fraser ME, Kwast Tvd, Bristow RG. Abstract NG06: The clinico-genomics of localized, non-indolent prostate cancer: the CPC-GENE experience Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Ng06 |
0.696 |
|
| 2018 |
Chua M, Bristow R, Murgic J, Hosni Abdalaty A, Salcedo A, Kamel-Reid S, Fraser M, Zhang J, Wang Q, Ch'ng C, Deheshi S, Davicioni E, Van der Kwast T, Boutros P, Berlin A. A Biopsy Based Genomic Classifier Predicts Biochemical Failure and Metastasis after Definitive Radiation without Hormone Therapy in a Prospective Cohort of Intermediate-Risk Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 102: S99. DOI: 10.1016/J.Ijrobp.2018.06.254 |
0.61 |
|
| 2017 |
Fraser M, Boutros PC, Bristow RG. A Partner in Crime: Tumor-associated Stroma and Metastatic Prostate Cancer. European Urology. PMID 29275835 DOI: 10.1016/J.Eururo.2017.11.029 |
0.674 |
|
| 2017 |
Hopkins JF, Sabelnykova VY, Weischenfeldt J, Simon R, Aguiar JA, Alkallas R, Heisler LE, Zhang J, Watson JD, Chua MLK, Fraser M, Favero F, Lawerenz C, Plass C, Sauter G, et al. Mitochondrial mutations drive prostate cancer aggression. Nature Communications. 8: 656. PMID 28939825 DOI: 10.1038/S41467-017-00377-Y |
0.574 |
|
| 2017 |
Kron KJ, Murison A, Zhou S, Huang V, Yamaguchi TN, Shiah YJ, Fraser M, van der Kwast T, Boutros PC, Bristow RG, Lupien M. TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer. Nature Genetics. PMID 28783165 DOI: 10.1038/Ng.3930 |
0.613 |
|
| 2017 |
Shiah YJ, Fraser M, Bristow RG, Boutros PC. Comparison of Pre-processing Methods for Infinium HumanMethylation450 BeadChip Array. Bioinformatics (Oxford, England). PMID 28605401 DOI: 10.1093/Bioinformatics/Btx372 |
0.399 |
|
| 2017 |
Chua MLK, Lo W, Pintilie M, Murgic J, Lalonde E, Bhandari V, Mahamud O, Gopalan A, Kweldam CF, van Leenders GJLH, Verhoef EI, Hoogland AM, Livingstone J, Berlin A, Dal Pra A, ... ... Fraser M, et al. A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies. European Urology. PMID 28511883 DOI: 10.1016/J.Eururo.2017.04.034 |
0.693 |
|
| 2017 |
Briollais L, Ozcelik H, Xu J, Kwiatkowski M, Lalonde E, Sendorek DH, Fleshner NE, Recker F, Kuk C, Olkhov-Mitsel E, Juvet T, Prassas I, Trachtenberg J, Toi A, Fraser M, et al. Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer. Journal of the National Cancer Institute. 109. PMID 28376164 DOI: 10.1093/Jnci/Djw258 |
0.694 |
|
| 2017 |
Fraser M, Sabelnykova VY, Yamaguchi TN, Heisler LE, Livingstone J, Huang V, Shiah YJ, Yousif F, Lin X, Masella AP, Fox NS, Xie M, Prokopec SD, Berlin A, Lalonde E, et al. Genomic hallmarks of localized, non-indolent prostate cancer. Nature. PMID 28068672 DOI: 10.1038/Nature20788 |
0.635 |
|
| 2017 |
Taylor RA, Fraser M, Livingstone J, Espiritu SM, Thorne H, Huang V, Lo W, Shiah YJ, Yamaguchi TN, Sliwinski A, Horsburgh S, Meng A, Heisler LE, Yu N, Yousif F, et al. Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories. Nature Communications. 8: 13671. PMID 28067867 DOI: 10.1038/Ncomms13671 |
0.629 |
|
| 2017 |
Fox NS, Lalonde E, Livingstone J, Hopkins J, Shiah Y, Huang V, Yamaguchi T, Sabelnykova V, Heisler L, Fraser M, van der Kwast T, Bristow RG, Boutros PC. Integrated somatic subtypes of localized intermediate-risk prostate cancer. Journal of Clinical Oncology. 35: e560-e560. DOI: 10.1200/Jco.2017.35.6_Suppl.E560 |
0.65 |
|
| 2017 |
Chua M, Holgersen E, Sabelnykova V, Salcedo A, Meng A, Fraser M, Van Der Kwast T, Boutros PC, Bristow RG. Genomic architecture of radioresistant prostate cancer. Journal of Clinical Oncology. 35: 26-26. DOI: 10.1200/Jco.2017.35.6_Suppl.26 |
0.676 |
|
| 2017 |
Chua MLK, Holgersen E, Sabelnykova V, Salcedo A, Meng A, Fraser M, Kwast Tvd, Boutros PC, Bristow RG. Abstract 5860: Genomic architecture of prostate cancer at recurrence following radiotherapy Cancer Research. 77: 5860-5860. DOI: 10.1158/1538-7445.Am2017-5860 |
0.693 |
|
| 2017 |
Briollais L, Ozcelik H, Xu J, Kwiatkowski M, Lalonde E, Sendorek DH, Fleshner NE, Recker F, Kuk C, Olkhov-Mitsel E, Savas S, Hanna S, Juvet T, Hunter GA, Friedlander M, ... ... Fraser M, et al. PD65-01 GERMLINE MUTATIONS IN THE KALLIKREIN 6 REGION AND PREDISPOSITION FOR AGGRESSIVE PROSTATE CANCER Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2951 |
0.572 |
|
| 2016 |
Lalonde E, Alkallas R, Chua ML, Fraser M, Haider S, Meng A, Zheng J, Yao CQ, Picard V, Orain M, Hovington H, Murgic J, Berlin A, Lacombe L, Bergeron A, et al. Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors. European Urology. PMID 27815082 DOI: 10.1016/J.Eururo.2016.10.013 |
0.672 |
|
| 2016 |
Chua ML, Salcedo A, Meng A, Zhang J, Fleshner N, Fraser M, van der Kwast T, Boutros PC, Bristow RG. Genomic Architecture of Prostate Cancer at Recurrence Following Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: S114. PMID 27675559 DOI: 10.1016/J.Ijrobp.2016.06.280 |
0.617 |
|
| 2016 |
So J, Chua ML, Lalonde E, Pra AD, Berlin A, Orain M, Hovington H, Bergeron A, Fradet Y, Têtu B, Meng A, Zhang J, Zafarana G, Livingstone J, Pintilie M, ... ... Fraser M, et al. Prognostic Significance of Tonsil Expression and the Homologous Recombination Pathway in Intermediate-Risk Prostate Cancer Recurrence. International Journal of Radiation Oncology, Biology, Physics. 96: S113. PMID 27675557 DOI: 10.1016/j.ijrobp.2016.06.278 |
0.64 |
|
| 2016 |
Guo H, Ahmed M, Zhang F, Yao CQ, Li S, Liang Y, Hua J, Soares F, Sun Y, Langstein J, Li Y, Poon C, Bailey SD, Desai K, Fei T, ... ... Fraser M, et al. Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer. Nature Genetics. PMID 27526323 DOI: 10.1038/Ng.3637 |
0.689 |
|
| 2016 |
Masella AP, Lalansingh CM, Sivasundaram P, Fraser M, Bristow RG, Boutros PC. BAMQL: a query language for extracting reads from BAM files. Bmc Bioinformatics. 17: 305. PMID 27516195 DOI: 10.1186/S12859-016-1162-Y |
0.346 |
|
| 2016 |
Boutros PC, Fraser M, van der Kwast T, Bristow RG. Clonality of localized and metastatic prostate cancer. Current Opinion in Urology. 26: 219-24. PMID 26885716 DOI: 10.1097/Mou.0000000000000279 |
0.687 |
|
| 2016 |
Chua M, Lalonde E, Mahamud O, Berlin A, Pra AD, Orain M, Picard V, Hovington H, Bergeron A, Fradet Y, Têtu B, Meng A, Zhang J, Zafarana G, Livingstone J, ... ... Fraser M, et al. Copy number alterations of DNA mismatch repair (MMR) genes as novel prognostic markers in localised prostate cancer (CaP). Journal of Clinical Oncology. 34: 96-96. DOI: 10.1200/Jco.2016.34.2_Suppl.96 |
0.584 |
|
| 2016 |
So J, Chua M, Lalonde E, Mahamud O, Berlin A, Dal Pra A, Orain M, Hovington H, Bergeron A, Fradet Y, Têtu B, Meng A, Zhang J, Zafarana G, Livingstone J, ... ... Fraser M, et al. Prognostic value of copy-number alterations of the Cohesin complex in intermediate-risk prostate cancer recurrence. Journal of Clinical Oncology. 34: 49-49. DOI: 10.1200/Jco.2016.34.2_Suppl.49 |
0.668 |
|
| 2016 |
Mahamud O, Chua M, Lalonde E, So J, Dal Pra A, Berlin A, Orain M, Picard V, Hovington H, Bergeron A, Fradet Y, Têtu B, Zafarana G, Meng A, Livingstone J, ... ... Fraser M, et al. Copy number alterations of P53, RB1, and MDM2 as prognostic markers in intermediate-risk prostate cancer. Journal of Clinical Oncology. 34: 117-117. DOI: 10.1200/Jco.2016.34.2_Suppl.117 |
0.586 |
|
| 2016 |
Chua M, Murgic J, Pintilie M, Lalonde E, Berlin A, Livingstone J, Dal Pra A, Meng A, Zhang J, Fradet Y, Têtu B, Fleshner NE, Fraser M, Boutros P, van der Kwast T, et al. Combinatorial genomic and pathological indices for integrated stratification of unfavorable intermediate-risk prostate cancer. Journal of Clinical Oncology. 34: 5051-5051. DOI: 10.1200/Jco.2016.34.15_Suppl.5051 |
0.661 |
|
| 2016 |
Hopkins JF, Sabelnykova VY, Watson J, Heisler LE, Zhang J, Fraser M, Kwast Tvd, Bristow RG, Boutros PC. Abstract 98: The somatic mutational landscape of the mitochondrial genome in prostate cancer: evaluation of clinical impact Cancer Research. 76: 98-98. DOI: 10.1158/1538-7445.Am2016-98 |
0.621 |
|
| 2016 |
Chua MLK, Murgic J, Pintilie M, Lalonde E, Kweldam C, Lo W, Berlin A, Pra AD, Orain M, Picard V, Hovington H, Begeron A, Fradet Y, Tetu B, Livingstone J, ... ... Fraser M, et al. Abstract 4339: Prognostic significance of copy number alteration burden in unfavorable intermediate-risk prostate cancers harboring intraductal carcinoma and cribriform architecture Cancer Research. 76: 4339-4339. DOI: 10.1158/1538-7445.Am2016-4339 |
0.611 |
|
| 2016 |
Fraser ME, Kwast Tvd, McPherson J, Collins CC, Fradet Y, Tetu B, Bergeron A, Bristow RG, Boutros PC. Abstract 118: A comprehensive profile of the genomic architecture of curable prostate cancer Cancer Research. 76: 118-118. DOI: 10.1158/1538-7445.Am2016-118 |
0.668 |
|
| 2016 |
So J, Chua M, Lalonde E, Mahamud O, Berlin A, Pra AD, Orain M, Hovington H, Bergeron A, Fradet Y, Têtu B, Meng A, Zhang J, Zafarana G, Pintilie M, ... ... Fraser M, et al. 227: Prognostic Significance of Tonsl Expression and the Homologous Recombination Pathway in Intermediate-Risk Prostate Cancer Recurrence Radiotherapy and Oncology. 120: S82-S83. DOI: 10.1016/S0167-8140(16)33626-X |
0.678 |
|
| 2015 |
Cooper CS, Eeles R, Wedge DC, Van Loo P, Gundem G, Alexandrov LB, Kremeyer B, Butler A, Lynch AG, Camacho N, Massie CE, Kay J, Luxton HJ, Edwards S, Kote-Jarai Z, ... ... Fraser M, et al. Corrigendum: Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nature Genetics. 47: 689. PMID 26018901 DOI: 10.1038/Ng0615-689B |
0.669 |
|
| 2015 |
Boutros PC, Fraser M, Harding NJ, de Borja R, Trudel D, Lalonde E, Meng A, Hennings-Yeomans PH, McPherson A, Sabelnykova VY, Zia A, Fox NS, Livingstone J, Shiah YJ, Wang J, et al. Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nature Genetics. 47: 736-45. PMID 26005866 DOI: 10.1038/Ng.3315 |
0.645 |
|
| 2015 |
Cooper CS, Eeles R, Wedge DC, Van Loo P, Gundem G, Alexandrov LB, Kremeyer B, Butler A, Lynch AG, Camacho N, Massie CE, Kay J, Luxton HJ, Edwards S, Kote-Jarai Z, ... ... Fraser M, et al. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nature Genetics. 47: 367-72. PMID 25730763 DOI: 10.1038/Ng.3221 |
0.676 |
|
| 2015 |
Fraser M, Berlin A, Bristow RG, van der Kwast T. Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer. Urologic Oncology. 33: 85-94. PMID 24768356 DOI: 10.1016/J.Urolonc.2013.10.020 |
0.667 |
|
| 2015 |
Fraser ME, Sabelnykova VY, Yamaguchi TN, Meng A, Heisler LE, Zhang J, Livingstone J, Huang V, Masella AP, Yousif F, Xie M, Harding NJ, Lin X, Kong H, Prokopec SD, et al. Abstract 2966: The mutational landscape of localized gleason 6 and 7 prostate cancer Cancer Research. 75: 2966-2966. DOI: 10.1158/1538-7445.Am2015-2966 |
0.672 |
|
| 2014 |
Zhukova N, Ramaswamy V, Remke M, Martin DC, Castelo-Branco P, Zhang CH, Fraser M, Tse K, Poon R, Shih DJ, Baskin B, Ray PN, Bouffet E, Dirks P, von Bueren AO, et al. WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma. Acta Neuropathologica Communications. 2: 174. PMID 25539912 DOI: 10.1186/S40478-014-0174-Y |
0.505 |
|
| 2014 |
Lalonde E, Ishkanian AS, Sykes J, Fraser M, Ross-Adams H, Erho N, Dunning MJ, Halim S, Lamb AD, Moon NC, Zafarana G, Warren AY, Meng X, Thoms J, Grzadkowski MR, et al. Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study. The Lancet. Oncology. 15: 1521-32. PMID 25456371 DOI: 10.1016/S1470-2045(14)71021-6 |
0.706 |
|
| 2014 |
Chong LC, Albuquerque MA, Harding NJ, Caloian C, Chan-Seng-Yue M, de Borja R, Fraser M, Denroche RE, Beck TA, van der Kwast T, Bristow RG, McPherson JD, Boutros PC. SeqControl: process control for DNA sequencing. Nature Methods. 11: 1071-5. PMID 25173705 DOI: 10.1038/Nmeth.3094 |
0.514 |
|
| 2014 |
Govind SK, Zia A, Hennings-Yeomans PH, Watson JD, Fraser M, Anghel C, Wyatt AW, van der Kwast T, Collins CC, McPherson JD, Bristow RG, Boutros PC. ShatterProof: operational detection and quantification of chromothripsis. Bmc Bioinformatics. 15: 78. PMID 24646301 DOI: 10.1186/1471-2105-15-78 |
0.546 |
|
| 2014 |
Miller JK, Buchner N, Timms L, Tam S, Luo X, Brown AM, Pasternack D, Bristow RG, Fraser M, Boutros PC, McPherson JD. Use of Sequenom sample ID Plus® SNP genotyping in identification of FFPE tumor samples. Plos One. 9: e88163. PMID 24551080 DOI: 10.1371/Journal.Pone.0088163 |
0.464 |
|
| 2014 |
Bristow R, Lalonde E, Milosevic M, Sykes J, Van der Kwast T, Fraser M, Fotouhi-Ghiam A, Boutros P. OC-0139: Complementarity of genomic instability & hypoxia indices for predicting prostate cancer recurrence Radiotherapy and Oncology. 111: S54. DOI: 10.1016/S0167-8140(15)30244-9 |
0.5 |
|
| 2013 |
Fraser ME, Borja Rd, Trudel D, Harding NJ, Hennings-Yeomans PH, Meng A, Lalonde ER, Brown A, Fox NS, Chong T, Zia A, Sam M, Wang J, Chan-Seng-Yue MA, Johns J, et al. Abstract 2003: A molecular portrait of potentially curable prostate cancer. Cancer Research. 73: 2003-2003. DOI: 10.1158/1538-7445.Am2013-2003 |
0.613 |
|
| 2013 |
Lalonde E, Boutros PC, Fraser M, Borja Rd, Harding NJ, Trudel D, Meng A, Hennings-Yeomans PH, McPherson A, Zia A, Wang J, Beck T, Fox NS, Chong T, Sam M, et al. Abstract B129: Clinical implications of inter- and intra- prostatic heterogeneity. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-B129 |
0.706 |
|
| 2013 |
Fraser M, Berlin A, Ouellet V, Saad F, Bristow RG. Prostate Cancer Genomics as a Driver of Personalized Medicine Cancer Genomics: From Bench to Personalized Medicine. 233-245. DOI: 10.1016/B978-0-12-396967-5.00014-1 |
0.661 |
|
| 2012 |
Fraser M, Zhao H, Luoto KR, Lundin C, Coackley C, Chan N, Joshua AM, Bismar TA, Evans A, Helleday T, Bristow RG. PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 1015-27. PMID 22114138 DOI: 10.1158/1078-0432.Ccr-11-2189 |
0.693 |
|
| 2012 |
Zhukova N, Martin D, Lipman T, Castelo-Branco P, Zhang CH, Fraser M, Baskin B, Ray P, Bouffet E, Bristow R, Alman BA, Taylor MD, Malkin D, Hawkins C, Tabori U. Abstract LB-210: Abrogation of mutant TP53 radiation resistance by lithium induced CTNNB1 (β-catenin) activation in medulloblastoma. Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-210 |
0.519 |
|
| 2012 |
Sam MR, Chong T, Zia A, Lalonde E, Yousif F, Denroche R, Chan-Seng-Yue M, Meng A, Fraser M, Johns J, Timms L, Borja Rd, Starmans MHW, Wang J, Hennings-Yeomans P, et al. Abstract 3184: Whole genome sequencing of low-input fresh frozen prostate cancer biopsies Cancer Research. 72: 3184-3184. DOI: 10.1158/1538-7445.Am2012-3184 |
0.67 |
|
| 2011 |
Fraser M, Harding SM, Zhao H, Coackley C, Durocher D, Bristow RG. MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks. Cell Cycle (Georgetown, Tex.). 10: 2218-32. PMID 21623170 DOI: 10.4161/Cc.10.13.16305 |
0.662 |
|
| 2011 |
Al-Bahlani S, Fraser M, Wong AY, Sayan BS, Bergeron R, Melino G, Tsang BK. P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism. Oncogene. 30: 4219-30. PMID 21516125 DOI: 10.1038/Onc.2011.134 |
0.532 |
|
| 2010 |
Fraser ME, Zhao H, Lundin C, Evans A, Helleday T, Bristow RG. Abstract 3932: Loss of PTEN sensitizes cells to DNA damaging agents in a RAD51-independent manner Cancer Research. 70: 3932-3932. DOI: 10.1158/1538-7445.Am10-3932 |
0.584 |
|
| 2009 |
Bristow RG, Zhao H, Fraser M. Abstract A122: The tyrosine kinase inhibitor MP470 inhibits RAD51‐mediated homologous recombination and increases tumor cell radio‐ and chemosensitivity Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A122 |
0.54 |
|
| 2008 |
Leung EL, Fraser M, Fiscus RR, Tsang BK. Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: Involvement in p53 regulation and cisplatin resistance British Journal of Cancer. 98: 1803-1809. PMID 18506185 DOI: 10.1038/Sj.Bjc.6604375 |
0.553 |
|
| 2008 |
Yang X, Fraser M, Abedini MR, Bai T, Tsang BK. Regulation of apoptosis-inducing factor-mediated, cisplatin-induced apoptosis by Akt. British Journal of Cancer. 98: 803-8. PMID 18283299 DOI: 10.1038/Sj.Bjc.6604223 |
0.537 |
|
| 2008 |
Fraser M, Bai T, Tsang BK. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function. International Journal of Cancer. 122: 534-46. PMID 17918180 DOI: 10.1002/Ijc.23086 |
0.569 |
|
| 2006 |
Yan X, Fraser M, Qiu Q, Tsang BK. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner. Gynecologic Oncology. 102: 348-55. PMID 16545436 DOI: 10.1016/J.Ygyno.2005.12.033 |
0.597 |
|
| 2006 |
Yang X, Fraser M, Moll UM, Basak A, Tsang BK. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway. Cancer Research. 66: 3126-36. PMID 16540663 DOI: 10.1158/0008-5472.Can-05-0425 |
0.535 |
|
| 2006 |
Fraser M, Chan SL, Chan SS, Fiscus RR, Tsang BK. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells. Oncogene. 25: 2203-12. PMID 16288207 DOI: 10.1038/Sj.Onc.1209251 |
0.552 |
|
| 2003 |
Fraser M, Leung BM, Yan X, Dan HC, Cheng JQ, Tsang BK. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells. Cancer Research. 63: 7081-8. PMID 14612499 |
0.525 |
|
| 2003 |
Fraser M, Leung B, Jahani-Asl A, Yan X, Thompson WE, Tsang BK. Chemoresistance in human ovarian cancer: the role of apoptotic regulators. Reproductive Biology and Endocrinology : Rb&E. 1: 66. PMID 14609433 DOI: 10.1186/1477-7827-1-66 |
0.588 |
|
| 2002 |
Cheng JQ, Jiang X, Fraser M, Li M, Dan HC, Sun M, Tsang BK. Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 5: 131-46. PMID 12237081 DOI: 10.1016/S1368-7646(02)00003-1 |
0.587 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2023 |
Grillo G, Keshavarzian T, Linder S, Arlidge C, Mout L, Nand A, Teng M, Qamra A, Zhou S, Kron KJ, Murison A, Hawley JR, Fraser M, van der Kwast TH, Raj GV, et al. Transposable elements are co-opted as oncogenic regulatory elements by lineage-specific transcription factors in prostate cancer. Cancer Discovery. PMID 37694973 DOI: 10.1158/2159-8290.CD-23-0331 |
0.29 |
|
| 2021 |
Luxenburger A, Bougen-Zhukov N, Fraser MG, Beetham H, Harris LD, Schmidt D, Cameron SA, Guilford PJ, Evans GB. Discovery of AL-GDa62 as a Potential Synthetic Lethal Lead for the Treatment of Gastric Cancer. Journal of Medicinal Chemistry. PMID 34878770 DOI: 10.1021/acs.jmedchem.1c01609 |
0.248 |
|
| 2021 |
Wagner H, Kenk M, Fraser M, Berlin A, Fleshner N. Biorepositories and Databanks for the Development of Novel Biomarkers for Genitourinary Cancer Prevention and Management. European Urology Focus. PMID 34167926 DOI: 10.1016/j.euf.2021.06.002 |
0.225 |
|
| 1997 |
Pittman S, Geyp M, Fraser M, Ellem K, Peaston A, Ireland C. Multiple centrosomal microtubule organising centres and increased microtubule stability are early features of VP-16-induced apoptosis in CCRF-CEM cells. Leukemia Research. 21: 491-9. PMID 9279360 DOI: 10.1016/S0145-2126(97)00038-6 |
0.114 |
|
| 2019 |
Dreyer BA, Amer T, Fraser M. Melanotan-induced priapism: a hard-earned tan. Bmj Case Reports. 12. PMID 30796078 DOI: 10.1136/bcr-2018-227644 |
0.079 |
|
| 1995 |
Bie W, Squire JA, Fraser M, Paterson MC, Godbout R. Mitochondrial ATP synthase alpha-subunit gene amplified in a retinoblastoma cell line maps to chromosome 18. Genes, Chromosomes & Cancer. 14: 63-7. PMID 8527386 DOI: 10.1002/Gcc.2870140111 |
0.066 |
|
| 2011 |
Fraser MR, Sechriest VF. Total knee arthroplasty in a patient with pseudopseudohypoparathyroidism. Orthopedics. 34: e413-7. PMID 21815586 DOI: 10.3928/01477447-20110627-30 |
0.057 |
|
| 2017 |
Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report. Clinical Toxicology (Philadelphia, Pa.). 55: 1072-1252. PMID 29185815 DOI: 10.1080/15563650.2017.1388087 |
0.056 |
|
| 2003 |
Bashir Z, Lafronza V, Fraser MR, Brown CK, Cope JR. Local and state collaboration for effective preparedness planning. Journal of Public Health Management and Practice : Jphmp. 9: 344-51. PMID 15503597 |
0.056 |
|
| 2005 |
Malakmadze N, González IM, Oemig T, Isiadinso I, Rembert D, McCauley MM, Wand P, Diem L, Cowan L, Palumbo GJ, Fraser M, Ijaz K. Unsuspected recent transmission of tuberculosis among high-risk groups: implications of universal tuberculosis genotyping in its detection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 366-73. PMID 15668858 DOI: 10.1086/427112 |
0.054 |
|
| 2022 |
Zeidan OA, Pepmiller E, Willoughby T, Li Z, Burkavage J, Harper B, Fraser M, Moffatt K, Meeks SL, Ramakrishna N. Operational Performance of a Compact Proton Therapy System: A 5-Year Experience. International Journal of Particle Therapy. 9: 10-19. PMID 36060418 DOI: 10.14338/IJPT-21-00033.1 |
0.05 |
|
| 2009 |
Neligan PJ, Malhotra G, Fraser M, Williams N, Greenblatt EP, Cereda M, Ochroch EA. Continuous positive airway fressure via the boussignac system immediately after extubation improves lung function in morbidly obese patients with obstructive sleep apnea undergoing laparoscopic bariatric surgery Anesthesiology. 110: 878-884. PMID 19293693 DOI: 10.1097/ALN.0b013e31819b5d8c |
0.049 |
|
| 2021 |
Kosk P, McKay A, McPhee A, Cowell D, Fraser M. Isolated nerve palsy following insertion of a three-piece inflatable penile prosthesis. Bjr Case Reports. 8: 20210158. PMID 36177264 DOI: 10.1259/bjrcr.20210158 |
0.048 |
|
| 2012 |
Staeheli GR, Fraser MR, Morgan SJ. The dangers of damage control orthopedics: a case report of vascular injury after femoral fracture external fixation. Patient Safety in Surgery. 6: 7. PMID 22443812 DOI: 10.1186/1754-9493-6-7 |
0.048 |
|
| 2022 |
Swallow JEN, Fraser MW, Kneusels NH, Charlton JF, Sole CG, Phelan CME, Björklund E, Bencok P, Escudero C, Pérez-Dieste V, Grey CP, Nicholls RJ, Weatherup RS. Revealing solid electrolyte interphase formation through interface-sensitive Operando X-ray absorption spectroscopy. Nature Communications. 13: 6070. PMID 36241622 DOI: 10.1038/s41467-022-33691-1 |
0.044 |
|
| 2003 |
Fraser MR. The local public health agency workforce: research needs and practice realities. Journal of Public Health Management and Practice : Jphmp. 9: 496-9. PMID 14606188 DOI: 10.1097/00124784-200311000-00009 |
0.044 |
|
| 2014 |
van der Salm H, Fraser MG, Horvath R, Cameron SA, Barnsley JE, Sun XZ, George MW, Gordon KC. Re(I) complexes of substituted dppz: a computational and spectroscopic study. Inorganic Chemistry. 53: 3126-40. PMID 24559053 DOI: 10.1021/Ic403056G |
0.043 |
|
| 2008 |
Sweeney CA, Oades GM, Fraser M, Palmer M. Does surgery have a role in management of chronic intrascrotal pain? Urology. 71: 1099-102. PMID 18436286 DOI: 10.1016/j.urology.2008.02.036 |
0.042 |
|
| 2010 |
Neligan PJ, Malhotra G, Fraser M, Williams N, Greenblatt EP, Cereda M, Ochroch EA. Noninvasive ventilation immediately after extubation improves lung function in morbidly obese patients with obstructive sleep apnea undergoing laparoscopic bariatric surgery (Retraction in: Anesthesia and Analgesia (2010) 111:2 (519)) Anesthesia and Analgesia. 110: 1360-1365. PMID 20418299 DOI: 10.1213/ANE.0b013e3181d5e3ef |
0.042 |
|
| 2021 |
Ruebush E, Fraser MR, Poulin A, Allen M, Lane JT, Blumenstock JS. COVID-19 Case Investigation and Contact Tracing: Early Lessons Learned and Future Opportunities. Journal of Public Health Management and Practice : Jphmp. 27: S87-S97. PMID 33239569 DOI: 10.1097/PHH.0000000000001290 |
0.039 |
|
| 2023 |
Leider JP, Castrucci BC, Robins M, Hare Bork R, Fraser MR, Savoia E, Piltch-Loeb R, Koh HK. The Exodus Of State And Local Public Health Employees: Separations Started Before And Continued Throughout COVID-19. Health Affairs (Project Hope). 42: 338-348. PMID 36877909 DOI: 10.1377/hlthaff.2022.01251 |
0.038 |
|
| 2020 |
Smith N, Fraser M. Straining the System: Novel Coronavirus (COVID-19) and Preparedness for Concomitant Disasters. American Journal of Public Health. e1-e2. PMID 32053389 DOI: 10.2105/AJPH.2020.305618 |
0.038 |
|
| 2021 |
Clarke C, Wheatley A, Fraser MR, Richey T, Ensign K. US-Affiliated Pacific Islands Response to COVID-19: Keys to Success and Important Lessons. Journal of Public Health Management and Practice : Jphmp. PMID 34561381 DOI: 10.1097/PHH.0000000000001443 |
0.036 |
|
| 2019 |
Law RKY, Kisselburgh H, Roblin D, Choudhary E, Schier J, Fraser M, Taylor E. Noninfectious Foodborne Exposures Reported to 2 National Reporting Systems, United States, 2000-2010. Public Health Reports (Washington, D.C. : 1974). 33354919862690. PMID 31386820 DOI: 10.1177/0033354919862690 |
0.036 |
|
| 2011 |
Fraser MG, Clark CA, Horvath R, Lind SJ, Blackman AG, Sun XZ, George MW, Gordon KC. Complete family of mono-, bi-, and trinuclear Re(I)(CO)3Cl complexes of the bridging polypyridyl ligand 2,3,8,9,14,15-hexamethyl-5,6,11,12,17,18-hexaazatrinapthalene: syn/anti isomer separation, characterization, and photophysics. Inorganic Chemistry. 50: 6093-106. PMID 21635016 DOI: 10.1021/Ic200136T |
0.035 |
|
| 2014 |
Larsen CB, van der Salm H, Clark CA, Elliott AB, Fraser MG, Horvath R, Lucas NT, Sun XZ, George MW, Gordon KC. Intraligand charge-transfer excited states in Re(I) complexes with donor-substituted dipyridophenazine ligands. Inorganic Chemistry. 53: 1339-54. PMID 24444107 DOI: 10.1021/Ic402082M |
0.035 |
|
| 2015 |
Horvath R, Fraser MG, Clark CA, Sun XZ, George MW, Gordon KC. Nature of Excited States of Ruthenium-Based Solar Cell Dyes in Solution: A Comprehensive Spectroscopic Study. Inorganic Chemistry. PMID 26630550 DOI: 10.1021/Acs.Inorgchem.5B01690 |
0.034 |
|
| 2016 |
Amer T, Wilson R, Chlosta P, AlBuheissi S, Qazi H, Fraser M, Aboumarzouk OM. Penile Fracture: A Meta-Analysis. Urologia Internationalis. PMID 26953932 DOI: 10.1159/000444884 |
0.033 |
|
| 2023 |
Barishansky RM, Fraser MR. Understanding Factors Influencing Decision Making by State Health Officials in a Public Health Emergency. Journal of Public Health Management and Practice : Jphmp. PMID 37104059 DOI: 10.1097/PHH.0000000000001761 |
0.033 |
|
| 2014 |
Dall R, Fraser MD, Desyatnikov AS, Li G, Brodbeck S, Kamp M, Schneider C, Höfling S, Ostrovskaya EA. Creation of orbital angular momentum states with chiral polaritonic lenses. Physical Review Letters. 113: 200404. PMID 25432029 DOI: 10.1103/PhysRevLett.113.200404 |
0.032 |
|
| 2020 |
Bayer E, Fraser MR, Plescia M. Leading Chronic Disease Prevention With Evidence-Based Policy: The ASTHO Example. Journal of Public Health Management and Practice : Jphmp. 26: 506-509. PMID 32732727 DOI: 10.1097/PHH.0000000000001242 |
0.032 |
|
| 2019 |
Locke R, Castrucci BC, Gambatese M, Sellers K, Fraser M. Unleashing the Creativity and Innovation of Our Greatest Resource-The Governmental Public Health Workforce. Journal of Public Health Management and Practice : Jphmp. 25: S96-S102. PMID 30720622 DOI: 10.1097/PHH.0000000000000973 |
0.031 |
|
| 2020 |
Kalyanaraman N, Fraser MR. Containing COVID-19 Through Contact Tracing : A Local Health Agency Approach. Public Health Reports (Washington, D.C. : 1974). 33354920967910. PMID 33170094 DOI: 10.1177/0033354920967910 |
0.031 |
|
| 2014 |
van der Salm H, Fraser MG, Horvath R, Turner JO, Greetham GM, Clark IP, Towrie M, Lucas NT, George MW, Gordon KC. Dual charge-transfer in rhenium(I) thioether substituted hexaazanaphthalene complexes. Inorganic Chemistry. 53: 13049-60. PMID 25469979 DOI: 10.1021/Ic502179F |
0.031 |
|
| 2023 |
Del Valle-Inclan Redondo Y, Schneider C, Klembt S, Höfling S, Tarucha S, Fraser MD. Optically Driven Rotation of Exciton-Polariton Condensates. Nano Letters. PMID 37129463 DOI: 10.1021/acs.nanolett.3c01021 |
0.03 |
|
| 2022 |
Pliska ES, Barfield WD, Fraser MR. Connecting the Dots: Public Health, Clinical, and Community Connections to Improve Contraception Access. American Journal of Public Health. 112: S508-S510. PMID 35767787 DOI: 10.2105/AJPH.2022.306924 |
0.03 |
|
| 2014 |
van der Salm H, Larsen CB, McLay JR, Fraser MG, Lucas NT, Gordon KC. Stretching the phenazine MO in dppz: the effect of phenyl and phenyl-ethynyl groups on the photophysics of Re(I) dppz complexes. Dalton Transactions (Cambridge, England : 2003). 43: 17775-85. PMID 25082233 DOI: 10.1039/C4Dt01415D |
0.03 |
|
| 2019 |
Fraser MR. A Brief History of the Prevention and Public Health Fund: Implications for Public Health Advocates. American Journal of Public Health. 109: 572-577. PMID 30789772 DOI: 10.2105/AJPH.2018.304926 |
0.03 |
|
| 2021 |
Fraser MR, Juliano C, Nichols G. Variation Among Public Health Interventions in Initial Efforts to Prevent and Control the Spread of COVID-19 in the 50 States, 29 Big Cities, and the District of Columbia. Journal of Public Health Management and Practice : Jphmp. 27: S29-S38. PMID 33239561 DOI: 10.1097/PHH.0000000000001284 |
0.029 |
|
| 2013 |
Horvath R, Fraser MG, Cameron SA, Blackman AG, Wagner P, Officer DL, Gordon KC. Synthesis, characterization, and photophysics of oxadiazole- and diphenylaniline-substituted Re(I) and Cu(I) complexes. Inorganic Chemistry. 52: 1304-17. PMID 23311357 DOI: 10.1021/Ic3018387 |
0.025 |
|
| 2015 |
Wang R, Fraser M, Li J, Qiao X, Wang A. Integrated in-fiber coupler for microsphere whispering-gallery modes resonator excitation. Optics Letters. 40: 308-11. PMID 25680034 DOI: 10.1364/Ol.40.000308 |
0.024 |
|
| 2019 |
Castrucci BC, Fraser M. Moving From Data to Action: Necessary Next Steps to a Better Governmental Public Health Workforce. Journal of Public Health Management and Practice : Jphmp. 25: S185-S187. PMID 30720633 DOI: 10.1097/PHH.0000000000000981 |
0.024 |
|
| 2022 |
Ruebush E, Dennison A, Lane JT, Harper-Hardy P, Poulin A, Prather B, Wright S, Harvey D, Fraser MR. Implementation of a Nationwide Knowledge-Based COVID-19 Contact Tracing Training Program, 2020. Public Health Reports (Washington, D.C. : 1974). 333549221101327. PMID 35786097 DOI: 10.1177/00333549221101327 |
0.023 |
|
| 2017 |
Fraser M, Castrucci BC. Beyond the Status Quo: 5 Strategic Moves to Position State and Territorial Public Health Agencies for an Uncertain Future. Journal of Public Health Management and Practice : Jphmp. 23: 543-551. PMID 28759558 DOI: 10.1097/PHH.0000000000000634 |
0.023 |
|
| 2013 |
Fraser MG, van der Salm H, Cameron SA, Blackman AG, Gordon KC. Heteroleptic Cu(I) bis-diimine complexes of 6,6'-dimesityl-2,2'-bipyridine: a structural, theoretical and spectroscopic study. Inorganic Chemistry. 52: 2980-92. PMID 23458499 DOI: 10.1021/Ic302393P |
0.022 |
|
| 2021 |
DeSalvo K, Hughes B, Bassett M, Benjamin G, Fraser M, Galea S, Gracia JN. Public Health COVID-19 Impact Assessment: Lessons Learned and Compelling Needs. Nam Perspectives. 2021. PMID 34532688 DOI: 10.31478/202104c |
0.021 |
|
| 2005 |
Estrada LC, Fraser MR, Cioffi JP, Sesker D, Walkner L, Brand MW, Kerby DS, Johnson DL, Cox G, Brewer L. Partnering for preparedness: the project public health ready experience. Public Health Reports (Washington, D.C. : 1974). 120: 69-75. PMID 16025710 |
0.02 |
|
| 2020 |
Fraser MR. Leading in the COVID-19 Crisis: Challenges and Solutions for State Health Leaders. Journal of Public Health Management and Practice : Jphmp. 26: 380-383. PMID 32433391 DOI: 10.1097/PHH.0000000000001192 |
0.02 |
|
| 2018 |
Fraser MR. Starting Out Right: What Are the Essential Elements of New State and Territorial Health Official Onboarding and Transition? Journal of Public Health Management and Practice : Jphmp. 24: 590-595. PMID 30273295 DOI: 10.1097/PHH.0000000000000898 |
0.019 |
|
| 2023 |
Swallow JEN, Jones ES, Head AR, Gibson JS, David RB, Fraser MW, van Spronsen MA, Xu S, Held G, Eren B, Weatherup RS. Revealing the Role of CO during CO Hydrogenation on Cu Surfaces with Soft X-Ray Spectroscopy. Journal of the American Chemical Society. PMID 36916242 DOI: 10.1021/jacs.2c12728 |
0.019 |
|
| 2002 |
Fraser MR, Buffington J, Lipson L, Meit M. Hepatitis C prevention programs: assessment of local health department capacity. Journal of Public Health Management and Practice : Jphmp. 8: 46-9. PMID 11889851 DOI: 10.1097/00124784-200203000-00006 |
0.019 |
|
| 2021 |
Fraser MR, Barishansky RM, Blumenstock JS. Twenty Years After 9/11: The Public Health Preparedness We Need Now. American Journal of Public Health. e1-e3. PMID 34383555 DOI: 10.2105/AJPH.2021.306459 |
0.017 |
|
| 2023 |
Cruz C, Wheatley A, Ensign K, Fraser MR, Gilmartin S, Bailey A, Mendiola A. Weaving and Layering Funding: A Territorial Health Agency's Guide to Effective Health Financing. Journal of Public Health Management and Practice : Jphmp. PMID 36943411 DOI: 10.1097/PHH.0000000000001709 |
0.017 |
|
| 2022 |
Baggett J, Fraser MR, Allen M, Plescia M. Sustained Management of COVID-19: Doing More of What Works to Control Future Surges. Journal of Public Health Management and Practice : Jphmp. 28: 580-583. PMID 35867509 DOI: 10.1097/PHH.0000000000001606 |
0.015 |
|
| 2019 |
Fraser M, Plescia M. The Opioid Epidemic's Prevention Problem. American Journal of Public Health. 109: 215-217. PMID 30649947 DOI: 10.2105/AJPH.2018.304859 |
0.015 |
|
| 2020 |
Fraser MR. State Policymaking and Prescription Drug-Monitoring Programs: A Look Ahead. American Journal of Public Health. 110: 1117-1118. PMID 32639913 DOI: 10.2105/AJPH.2020.305762 |
0.014 |
|
| 2016 |
Fraser MD, Höfling S, Yamamoto Y. Physics and applications of exciton-polariton lasers. Nature Materials. 15: 1049-52. PMID 27658448 DOI: 10.1038/Nmat4762 |
0.014 |
|
| 2018 |
Levine M, Fraser M. Elements of a Comprehensive Public Health Response to the Opioid Crisis. Annals of Internal Medicine. PMID 30398529 DOI: 10.7326/M18-1757 |
0.013 |
|
| 2022 |
Fraser MR. Harassment of Health Officials: A Significant Threat to the Public's Health. American Journal of Public Health. 112: 728-730. PMID 35298236 DOI: 10.2105/AJPH.2022.306797 |
0.011 |
|
| 2022 |
Hare Bork R, Castrucci BC, Fraser MR. PH WINS: Necessary, Actionable Public Health Workforce Data at a Pivotal Moment for the Field. Journal of Public Health Management and Practice : Jphmp. 29: S1-S3. PMID 36448746 DOI: 10.1097/PHH.0000000000001676 |
0.011 |
|
| 2017 |
Fraser MR, Hardy G. ASTHO at 75: Celebrating the Past and Preparing for the Future. Journal of Public Health Management and Practice : Jphmp. 23: 518-523. PMID 28759554 DOI: 10.1097/PHH.0000000000000629 |
0.011 |
|
| 2013 |
Fraser MR. Bringing it all together: effective maternal and child health practice as a means to improve public health. Maternal and Child Health Journal. 17: 767-75. PMID 22722915 DOI: 10.1007/s10995-012-1064-1 |
0.01 |
|
| 2021 |
Tewarson H, Greene K, Fraser MR. State Strategies for Addressing Barriers During the Early US COVID-19 Vaccination Campaign. American Journal of Public Health. 111: 1073-1077. PMID 33950715 DOI: 10.2105/AJPH.2021.306241 |
0.01 |
|
| 2021 |
Fraser MR, Blumenstock J. Lessons Relearned? H1N1, COVID-19, and Vaccination Planning. Journal of Public Health Management and Practice : Jphmp. 27: S106-S110. PMID 33239572 DOI: 10.1097/PHH.0000000000001289 |
0.01 |
|
| 2021 |
Halverson PK, Yeager VA, Menachemi N, Fraser MR, Freeman LT. Public Health Officials and COVID-19: Leadership, Politics, and the Pandemic. Journal of Public Health Management and Practice : Jphmp. 27: S11-S13. PMID 33239558 DOI: 10.1097/PHH.0000000000001281 |
0.01 |
|
| 2021 |
Juliano C, Castrucci B, Fraser MR. COVID-19 and Public Health: Looking Back, Moving Forward. Journal of Public Health Management and Practice : Jphmp. 27: S1-S4. PMID 33239556 DOI: 10.1097/PHH.0000000000001300 |
0.01 |
|
| 2019 |
Fraser MR. Blinding Me With Science: Complementary "Head" and "Heart" Messages Are Needed to Counter Rising Vaccine Hesitancy. Journal of Public Health Management and Practice : Jphmp. 25: 511-514. PMID 31348167 DOI: 10.1097/PHH.0000000000001065 |
0.01 |
|
| 2019 |
Fraser M. Editorial Comment. The Journal of Urology. 202: 95. PMID 30977696 DOI: 10.1097/01.JU.0000558067.55878.d2 |
0.01 |
|
| 2017 |
Fraser M, Castrucci B, Harper E. Public Health Leadership and Management in the Era of Public Health 3.0. Journal of Public Health Management and Practice : Jphmp. 23: 90-92. PMID 27870719 DOI: 10.1097/PHH.0000000000000527 |
0.01 |
|
| 2010 |
Fraser MG, Blackman AG, Irwin GI, Easton CP, Gordon KC. Effect of sulfur-based substituents on the electronic properties of Re(I) dppz complexes. Inorganic Chemistry. 49: 5180-9. PMID 20465244 DOI: 10.1021/Ic1003116 |
0.01 |
|
| 2009 |
Ramsey S, Sweeney C, Fraser M, Oades G. Pubic hair and sexuality: a review. The Journal of Sexual Medicine. 6: 2102-10. PMID 19453886 DOI: 10.1111/j.1743-6109.2009.01307.x |
0.01 |
|
| 2007 |
Fraser MR. After 5 years of public health preparedness, are we ready yet? Journal of Public Health Management and Practice : Jphmp. 13: 3-6. PMID 17149093 DOI: 10.1097/00124784-200701000-00002 |
0.01 |
|
| Hide low-probability matches. |